While in vitro models can provide insight into many aspects of viral infection, in vivo models are critical to the understanding of the pathogenesis and treatment of viral diseases. The recent development and use of animal models that display pathology following infection with human immunodeficiency virus type 1 (HIV-1) has significantly expanded our knowledge of the mechanisms associated with viral pathogenesis and provided an impetus towards the development of therapeutic approaches. The development of humanized mouse models has provided novel model systems with which to study the human immune system and the effects of HIV infection on human cells and tissues. These models involve transplantation of various types of human tissues into mice who possess one or more of several types of immune defects. The human tissue can then engraft, grow and develop in a similar fashion as it would in humans, allowing the study of this tissue in a living system. The human tissue used in these studies is capable of a high degree of manipulation and experimentation in the mouse and the human cells, versus the mouse cells, are further susceptible to infection with HIV. This provides a powerful model to examine human bloods cell development, to study the effects of HIV infection on human cells, and ways to protect the human immune system from HIV. The generation of these humanized mice is a highly specialized procedure, due to the requirement for immunodeficient mouse strains, human hematopoietic tissue, infectious material, specialized facilities, and the necessary skill and knowledge to perform experiments in this system. The CFAR supported Humanized Mouse Core is designed to assist AIDS-related investigators at UCLA with their research by providing all of the resources and the environments necessary to support the use of state-of-the art humanized mouse technologies. This facility will support the use of humanized mice for AIDS-related research under both Biosafety Level 2 and Biosafety Level 2+ conditions. This facility will also provide consultation on the use of humanized mouse models, as well as construct various humanized animals for distribution to Core users. Thus, the overall goal of this Core laboratory is to provide the infrastructure, materials, animals, technical expertise and support that will facilitate the use of humanized immunodeficient mice in AIDS-related studies

Public Health Relevance

The overall relevance of the UCLA CFAR Humanized Mouse Core Laboratory is in the ability to provide state-of-the-art resources, expertise, services, and infrastructure involved in AIDS-related humanized mouse-based experiments.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-UKS-A (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Cisneros, Irma E; Erdenizmenli, Mert; Cunningham, Kathryn A et al. (2018) Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. Neuropharmacology 135:431-443
Marsden, Matthew D; Wu, Xiaomeng; Navab, Sara M et al. (2018) Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents. Virology 520:83-93
Yu, Jingyi; Seldin, Marcus M; Fu, Kai et al. (2018) Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity. Circ Res 123:73-85
de la Torre-Ubieta, Luis; Stein, Jason L; Won, Hyejung et al. (2018) The Dynamic Landscape of Open Chromatin during Human Cortical Neurogenesis. Cell 172:289-304.e18
Epeldegui, Marta; Magpantay, Larry; Guo, Yu et al. (2018) A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma. AIDS 32:945-954
Kiertscher, Sylvia M; Gangalum, Pallavi R; Ibrahim, Grace et al. (2018) A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol 13:219-229
Swendeman, Dallas; Comulada, Warren Scott; Koussa, Maryann et al. (2018) Longitudinal Validity and Reliability of Brief Smartphone Self-Monitoring of Diet, Stress, and Physical Activity in a Diverse Sample of Mothers. JMIR Mhealth Uhealth 6:e176
Swendeman, Dallas; Fehrenbacher, Anne E; Roy, Soma et al. (2018) Gender disparities in depression severity and coping among people living with HIV/AIDS in Kolkata, India. PLoS One 13:e0207055
Beymer, Matthew R; Kofron, Ryan M; Tseng, Chi-Hong et al. (2018) Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County. Int J STD AIDS 29:557-562
Matassoli, Flávio Lemos; Leão, Ihid Carneiro; Bezerra, Bruno Braz et al. (2018) Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation. mSphere 3:

Showing the most recent 10 out of 942 publications